Researchers offer new treatment protocol for advanced head and neck cancer
The current treatment of patients diagnosed with advanced or metastatic head and neck cancer (HNC) is ineffective. Researchers have investigated and validated a potential treatment combination against the aggressive disease driven by hyper-activation of a specific signaling pathway, which is found in over 40 percent of HNC patients.
Materials provided by Ben-Gurion University of the Negev. Note: Content may be edited for style and length.
Source link aaaaa